 | Up a level |
Ørnbjerg, Lykke Midtbøll; Rugbjerg, Kathrine; Georgiadis, Stylianos; Rasmussen, Simon Horskjær; Jacobsson, Lennart; Loft, Anne Gitte; Iannone, Florenzo; Fagerli, Karen Minde; Vencovsky, Jiri; Santos, Maria José; Möller, Burkhard; Pombo-Suarez, Manuel; Rotar, Ziga; Gudbjornsson, Bjorn; Cefle, Ayse; Eklund, Kari; Codreanu, Catalin; Jones, Gareth; van der Sande, Marleen; Wallman, Johan Karlsson; ... (2024). Patient-reported outcomes and PRO remission rates in 12,262 biologic-naïve patients with psoriatic arthritis treated with TNF-inhibitors in routine care. The journal of rheumatology, 51(4), pp. 378-389. The Journal of Rheumatology Publishing Company Limited 10.3899/jrheum.2023-0764
Linde, Louise; Ørnbjerg, Lykke M; Georgiadis, Stylianos; Rasmussen, Simon H; Lindström, Ulf; Askling, Johan; Michelsen, Brigitte; Di Giuseppe, Daniela; Wallman, Johan K; Gudbjornsson, Bjorn; Love, Thorvardur Jon; Nordström, Dan C; Yli-Kerttula, Timo; Nekvindová, Lucie; Vencovský, Jiří; Iannone, Florenzo; Cauli, Alberto; Loft, Anne Gitte; Glintborg, Bente; Laas, Karin; ... (2024). Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF-inhibitor: results from 13 European registries. Rheumatology, 63(3), pp. 751-764. Oxford University Press 10.1093/rheumatology/kead284
